Katarzyna Stankowska Selected Research

Katarzyna Stankowska Research Topics

2	Peripheral Arterial Disease 11/2016 - 11/2015
2	Ischemia 11/2016 - 03/2012
2	Essential Thrombocythemia 10/2016 - 07/2014
1	Neoplasms (Cancer) 01/2017
1	Obesity 11/2016
1	Overweight 11/2016
1	Thrombosis (Thrombus) 05/2016
1	Myocardial Infarction 01/2016
1	ST Elevation Myocardial Infarction 01/2016
1	Type 2 Diabetes Mellitus (MODY) 11/2015
1	Body Weight (Weight, Body) 05/2015
1	Insulin Resistance 05/2015
1	Morbid Obesity 05/2015
1	Weight Loss (Weight Reduction) 05/2015
1	Polycythemia Vera 07/2014
1	Primary Myelofibrosis (Myelosclerosis) 07/2014
1	Acute Coronary Syndrome 01/2014

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2015
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2016 - 05/2016
1	N 30IBA 11/2016
1	Janus Kinase 2IBA 10/2016
1	Thromboplastin (Tissue Factor)IBA 10/2016
1	TicagrelorIBA 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2015
1	Angiogenesis InhibitorsIBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2015
1	C-Reactive ProteinIBA 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2015
1	HDL LipoproteinsIBA 05/2015
1	HDL CholesterolIBA 05/2015
1	Triglycerides (Triacylglycerol)IBA 05/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2015
1	fibrin fragment D (D-dimer)IBA 07/2014
1	Clopidogrel (Plavix)FDA Link 01/2014
1	Prasugrel Hydrochloride FDA Link 01/2014
1	erucylphosphocholineIBA 03/2012

1	Therapeutics 11/2015
1	Balneology 05/2015
1	Caloric Restriction 05/2015
1	Percutaneous Coronary Intervention 01/2014